Bio Protocol vs Hive — how do they compare? Bio Protocol trades at Rp513.64 (market cap Rp1,16T, Rp252,63M 24h volume), while Hive trades at Rp875.37 (market cap Rp493,14M, Rp27,39M 24h volume). The key difference: Bio Protocol is far larger — about 2352.3× Hive's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Hive's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Hive for 41 Days on average.
| BIO | HIVE | |
|---|---|---|
Market Cap | Rp1,16T | Rp493,14M |
Volume (24h) | Rp252,63M | Rp27,39M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 566,3M HIVE |
Typical Hold Time | 16 Days | 41 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →HIVE is a decentralized information sharing network with an accompanying blockchain-based financial ledger built on the Delegated Proof of Stake (DPoS) protocol. Hive is developed to store vast amounts of content and to make it available for time-based monetization. Examples of use include social media with monetized rewards for content producers, interactive games, identity management, polling systems, and micro-loans.
Read more on HIVE →